--- title: "BriaCell Therapeutics (BCTX) news: going concern and offering" url: "https://aibio.space/companies/briacell-therapeutics-bctx/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "BCTX going concern and offering news: BriaCell closes best efforts offering of 1,449,300 shares at $3.25, raising $4.71 million gross." --- BCTX BriaCell Therapeutics Corp. NASDAQ · Not recorded # BriaCell Therapeutics (BCTX) news BCTX going concern and offering news Financings · 2026-06-03 ## [BriaCell closes best efforts offering of 1,449,300 shares at $3.25, raising $4.71 million gross](https://aibio.space/news/briacell-closes-best-efforts-offering-1-449-300-shares-3-25-raising-4/) BriaCell sold 1,449,300 common shares at $3.25 in a best efforts offering for gross proceeds of $4.71 million. ThinkEquity LLC was sole placement agent, with a 7.5% cash fee and warrants for 72,465 shares, and the company's 10-K carries a going-concern warning. ## Latest BriaCell Therapeutics news 1. 2026-01-13 Financings [BriaCell prices $30 million offering of units with warrants through ThinkEquity](https://aibio.space/news/briacell-prices-30-million-offering-units-warrants-through-thinkequity/) BriaCell Therapeutics sold 5.4 million units at $5.59, each with a five-year warrant struck at $6.93. The best-efforts deal closed Jan. 15. 2. 2025-08-26 Listings [BriaCell plans 1-for-10 share consolidation to meet Nasdaq listing rules](https://aibio.space/news/briacell-plans-1-10-share-consolidation-meet-nasdaq-listing-rules/) BriaCell's board approved a one-for-ten share consolidation to keep its Nasdaq listing, expected to take effect August 25, 2025, subject to approval from Nasdaq and the Toronto Stock Exchange. 3. 2025-02-13 Listings [BriaCell Therapeutics regains compliance with Nasdaq minimum bid price requirement](https://aibio.space/news/briacell-therapeutics-regains-compliance-nasdaq-minimum-bid-price/) Nasdaq closed BriaCell's bid price matter on February 12, 2025, after an August 2024 letter cited 30 consecutive business days with closing bids below $1.00. 4. 2025-02-05 Financings [BriaCell closes $3.05 million best-efforts public offering of 762,500 shares at $4.00](https://aibio.space/news/briacell-closes-3-05-million-best-efforts-public-offering-762-500/) BriaCell sold 762,500 common shares at $4.00 each through placement agent ThinkEquity. The $3.05 million in gross proceeds is before fees and expenses, and the agent also received warrants on 38,125 shares. ## BriaCell Therapeutics at a glance - **Ticker**: BCTX - **Listing**: NASDAQ - **Country**: Not recorded ### Related companies - [ASP Isotopes](https://aibio.space/companies/asp-isotopes/) NASDAQ: ASPI - [Tempus AI](https://aibio.space/companies/tempus-ai/) NASDAQ: TEM - [Hercules Capital](https://aibio.space/companies/hercules-capital/) NYSE: HTGC - [IRulya Therapeutics](https://aibio.space/companies/irulya-therapeutics-qncx/) NASDAQ: QNCX - [Goldman Sachs Group](https://aibio.space/companies/goldman-sachs/) NYSE: GS ### Also on NASDAQ - [AgomAb Therapeutics NV](https://aibio.space/companies/agomab-therapeutics/) AGMB - [Dyadic International](https://aibio.space/companies/dyadic-international/) DYAI - [CVRx](https://aibio.space/companies/cvrx/) CVRX - [Akari Therapeutics Plc](https://aibio.space/companies/akari-therapeutics/) AKTX - [bioAffinity Technologies](https://aibio.space/companies/bioaffinity-technologies/) BIAF - [Intellia Therapeutics](https://aibio.space/companies/intellia-therapeutics/) NTLA ## Questions about BriaCell Therapeutics Has BriaCell Therapeutics issued a going-concern warning? Our latest story on this, dated Jun 3, 2026: "BriaCell closes best efforts offering of 1,449,300 shares at $3.25, raising $4.71 million gross". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/briacell-closes-best-efforts-offering-1-449-300-shares-3-25-raising-4/). Has BriaCell Therapeutics raised money recently? Our latest story on this, dated Jun 3, 2026: "BriaCell closes best efforts offering of 1,449,300 shares at $3.25, raising $4.71 million gross". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/briacell-closes-best-efforts-offering-1-449-300-shares-3-25-raising-4/). What is the ticker symbol of BriaCell Therapeutics? BriaCell Therapeutics Corp. trades under the ticker BCTX on NASDAQ. Where is BriaCell Therapeutics listed? BriaCell Therapeutics Corp. is listed on NASDAQ. Which country or territory is BriaCell Therapeutics listed under? Our directory records BriaCell Therapeutics Corp. under Not recorded. Does aibio.space cover BriaCell Therapeutics? aibio.space lists BriaCell Therapeutics Corp. among 2,820 public biotech companies and publishes its news here as stories appear. What is the latest BriaCell Therapeutics (BCTX) stock news? Our latest story on BriaCell Therapeutics, dated Jun 3, 2026: "BriaCell closes best efforts offering of 1,449,300 shares at $3.25, raising $4.71 million gross". BriaCell sold 1,449,300 common shares at $3.25 in a best efforts offering for gross proceeds of $4.71 million. ThinkEquity LLC was sole placement agent, with a 7.5% cash fee and warrants for 72,465 shares, and the company's 10-K carries a going-concern warning. [Source](https://aibio.space/news/briacell-closes-best-efforts-offering-1-449-300-shares-3-25-raising-4/). How long will BriaCell Therapeutics's cash last? From our story of Jun 3, 2026: ThinkEquity LLC was sole placement agent, with a 7.5% cash fee and warrants for 72,465 shares, and the company's 10-K carries a going-concern warning. [Source](https://aibio.space/news/briacell-closes-best-efforts-offering-1-449-300-shares-3-25-raising-4/). Is BriaCell Therapeutics at risk of delisting? Our latest listing story, dated Aug 26, 2025: "BriaCell plans 1-for-10 share consolidation to meet Nasdaq listing rules". BriaCell's board approved a one-for-ten share consolidation to keep its Nasdaq listing, expected to take effect August 25, 2025, subject to approval from Nasdaq and the Toronto Stock Exchange. [Source](https://aibio.space/news/briacell-plans-1-10-share-consolidation-meet-nasdaq-listing-rules/). How can I follow BriaCell Therapeutics (BCTX) news? Press Follow on this page to add BriaCell Therapeutics to your Following list, or subscribe to the aibio.space newsletter. We have published 5 stories naming BriaCell Therapeutics so far, in Financings, Listings. ## Investor discussion: BriaCell Therapeutics Members talk about BriaCell Therapeutics (BCTX). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:BCTX on TradingView](https://www.tradingview.com/symbols/NASDAQ-BCTX/). ## Listing details BriaCell Therapeutics Corp. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker BCTX, recorded under Not recorded. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: BriaCell Therapeutics Corp. - **Ticker**: BCTX - **Listing**: NASDAQ - **Country or territory**: Not recorded Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/briacell-therapeutics-bctx/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "BriaCell Therapeutics (BCTX) news: going concern and offering", 2026-10-31, https://aibio.space/companies/briacell-therapeutics-bctx/